Cargando…

2269. Clinical Outcomes in Patients with Carbapenem-Non-Susceptible, β-Lactam-Susceptible Pseudomonas aeruginosa Infections

BACKGROUND: Pseudomonas aeruginosa (PsAr) isolates harboring OprD mutations often present phenotypically as carbapenem nonsusceptible but susceptible to antipseudomonal β-lactams (APBLs). It is unknown whether this unique genotype–phenotype combination affects the clinical outcomes of patients infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gavaghan, Victoria M, Lee, Michelle, Butler, David, Biagi, Mark, Santarossa, Maressa, Harrington, Amanda, Albarillo, Fritzie S, Wenzler, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810814/ http://dx.doi.org/10.1093/ofid/ofz360.1947

Ejemplares similares

2585. Identification of Risk Factors for Pseudomonas aeruginosa in Patients with Community-Acquired Pneumonia
por: Karajeh, Jenna, et al.
Publicado: (2023)

In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient
por: Wenzler, Eric, et al.
Publicado: (2020)

602. Clinical Outcomes of Ertapenem in Patients with Hypoalbuminemia
por: Gavaghan, Victoria, et al.
Publicado: (2022)

BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department
por: Santarossa, Maressa, et al.
Publicado: (2019)

1051. The Use of Survey-Driven Feedback to Improve Antimicrobial Stewardship Efforts at a Single Center
por: Albarillo, Fritzie S, et al.
Publicado: (2019)

Mortality in patients with carbapenem-resistant Pseudomonas aeruginosa with and without susceptibility to traditional antipseudomonal β-lactams
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

2036. A Quasi-Experimental Survey Study of Antimicrobial Stewardship Education for Registered Nurses
por: Santarossa, Maressa, et al.
Publicado: (2019)

969. The Importance of a Strong Handshake: Expanding Antimicrobial Stewardship to Engage Frontline Providers in Adult Medicine
por: Sapozhnikov, Julia, et al.
Publicado: (2022)

Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile
por: Pragasam, Agila K., et al.
Publicado: (2016)

Distinctive Regulation of Carbapenem Susceptibility in Pseudomonas aeruginosa by Hfq
por: Sonnleitner, Elisabeth, et al.
Publicado: (2020)

834. Clinical Outcomes with Carbapenem-Resistant Pseudomonas aeruginosa that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018
por: Howard-Anderson, Jessica, et al.
Publicado: (2020)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

1600. Susceptibility of β-Lactam-Resistant Pseudomonas aeruginosa to Other β-Lactams: Is There Truly a Lack of Cross-Resistance?
por: Patel, Twisha S, et al.
Publicado: (2019)

Introducing antimicrobial stewardship to the outpatient clinics of a suburban academic health system
por: Nielsen, Travis B., et al.
Publicado: (2022)

1750. Evaluation of Antibiotic Allergy in the Ambulatory Setting
por: Yi, Sarah M, et al.
Publicado: (2022)

Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria
por: Meradji, Samah, et al.
Publicado: (2015)

247. Validation of the Use of Oral Vancomycin Following Positive Admission Screening Testing for C. difficile
por: Yeturu, Preethi, et al.
Publicado: (2020)

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
por: Abbey, Taylor, et al.
Publicado: (2022)

Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to “Old” Cephalosporins and/or to Penicillins
por: Zaidenstein, Ronit, et al.
Publicado: (2018)

142. Implementing an Antimicrobial Stewardship Program in the Outpatient Setting
por: Nielsen, Travis B, et al.
Publicado: (2020)

722. Risk Factors for Infection or Colonization with Ceftolozane/Tazobactam Non-Susceptible Extensively β-Lactam Resistant Pseudomonas aeruginosa
por: Lee, Michelle, et al.
Publicado: (2023)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa
por: Gill, Christian M, et al.
Publicado: (2022)

Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients With Diabetic Foot Infections
por: Veve, Michael P, et al.
Publicado: (2022)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of Acinetobacter baumannii and Pseudomonas aeruginosa in an Academic Medical Center in Thailand
por: Paiboonvong, Taniya, et al.
Publicado: (2022)

Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing
por: Gajdács, Márió
Publicado: (2020)

Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa
por: Atrissi, Jad, et al.
Publicado: (2021)

A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections
por: Shi, Qingyi, et al.
Publicado: (2019)

588. Ceftolozane/Tazobactam Susceptibility of Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacterales Isolates in a Tertiary Hospital in Korea
por: Kim, Kye-Hyung, et al.
Publicado: (2023)

Mortality associated with carbapenem-susceptible and Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa bacteremia
por: Persoon, Marjolein C., et al.
Publicado: (2020)

Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan
por: Tseng, Sung-Pin, et al.
Publicado: (2009)

Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil
por: Campana, Eloiza Helena, et al.
Publicado: (2016)

Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant Pseudomonas aeruginosa in patients with nosocomial pneumonia
por: Liu, Yao, et al.
Publicado: (2023)

Optimized β-Lactam Therapy Improves Survival in Carbapenem Non-Susceptible Gram-Negative Infections
por: Flynt, Lauren K, et al.
Publicado: (2017)

Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa
por: Lee, Su Young, et al.
Publicado: (2023)

1450. Frequency of Carbapenem-resistant Pseudomonas aeruginosa Among Respiratory Pathogens Impacts First-Line Beta-Lactam Susceptibility: Potential Role for Ceftolozane/Tazobactam (C/T) and/or Imipenem/Relebactam (I/R)
por: Klinker, Kenneth, et al.
Publicado: (2020)

Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
por: Skalweit, Marion J, et al.
Publicado: (2016)

Susceptibility Rates of Pseudomonas Aeruginosa Strains to Quinolones
por: Adhikari, Luna, et al.
Publicado: (2010)

2125. Activity of Novel β-Lactam/β-Lactamase Inhibitor Combinations against Serine-Carbapenemase producing Carbapenem-Resistant Pseudomonas aeruginosa
por: Lee, Su Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u8nkt36q86ndq23v6hv7vhndlu